Cargando…

Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: results from the E-Five Registry

OBJECTIVE: To retrospectively evaluate the 12-month effectiveness of the Endeavor zotarolimus-eluting stent (ZES) in diabetic versus non-diabetic patients enrolled in the E-Five Registry. DESIGN AND SETTING: The E-Five Registry is a prospective, multicentre registry of 8314 patients presenting with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jain, Ajay K, Lotan, Chaim, Meredith, Ian T, Feres, Faustos, Zambahari, Robaayah, Sinha, Nakul, Rothman, Martin T
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Group 2010
Materias:	Interventional Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921264/ https://www.ncbi.nlm.nih.gov/pubmed/20478863 http://dx.doi.org/10.1136/hrt.2009.184150

Ejemplares similares

Comparison of short-term clinical outcomes between Resolute Onyx zotarolimus-eluting stents and everolimus-eluting stent in patients with acute myocardial infarction: Results from the Korea Acute Myocardial infarction Registry (KAMIR)
por: Kim, Yongcheol, et al.
Publicado: (2019)

Biodegradable polymer-coated thin strut sirolimus-eluting stent versus durable polymer-coated everolimus-eluting stent in the diabetic population
por: Gasior, Pawel, et al.
Publicado: (2021)

Multianalysis with optical coherence tomography and vasomotion in everolimus-eluting stents and everolimus-eluting biovascular scaffolds: the MOVES trial
por: Arroyo, Diego A, et al.
Publicado: (2018)

Assessment of anti-dislodgment capability for contemporary drug eluting stents
por: Ye, Yicong, et al.
Publicado: (2021)

“Burying” covered coronary stents under drug-eluting stents: A novel approach to ensure long-term stent patency
por: Bossard, Matthias, et al.
Publicado: (2023)

Open-labeled randomized controlled trial to evaluate the 1-year clinical outcomes of polymer-free sirolimus-eluting coronary stents as compared with biodegradable polymer-based sirolimus-eluting coronary stents
por: Viswanathan, Sunitha, et al.
Publicado: (2018)

Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography
por: Chen, B X, et al.
Publicado: (2008)

Randomised trial of the comparison of drug-eluting stents in patients with diabetes: OCT DES trial
por: Hamshere, Stephen, et al.
Publicado: (2018)

Polymer-free sirolimus-eluting stents in a large-scale all-comers population
por: Krackhardt, Florian, et al.
Publicado: (2017)

Recanalization of in-stent chronic total occlusion using intravascular lithotripsy and Firehawk(®) rapamycin target eluting coronary stents: A case report
por: Patrascu, Alexandru, et al.
Publicado: (2021)

Efficacy and safety of drug-eluting stents in elderly patients: A meta-analysis of randomized trials
por: Bae, SungA, et al.
Publicado: (2021)

Zotarolimus-eluting stent-induced hypersensitivity pneumonitis
por: Shin, Hong-Won, et al.
Publicado: (2013)

Ultrathin-strut biodegradable polymer versus durable polymer drug-eluting stents: a meta-analysis
por: Monjur, Mohammad Riashad, et al.
Publicado: (2020)

Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold
por: Madanchi, Mehdi, et al.
Publicado: (2021)

Seven-year clinical outcomes in patients undergoing percutaneous coronary intervention with biodegradable polymer coated sirolimus-eluting stent: Results from a single-center real-world experience
por: Abhyankar, Atul, et al.
Publicado: (2018)

Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction
por: Remkes, Wouter S, et al.
Publicado: (2016)

One-year clinical outcome of percutaneous coronary intervention with very long (≥ 40 mm) drug-eluting stent
por: Rajesh, Gopalan Nair, et al.
Publicado: (2018)

Advances in drug eluting stents – focus on the Endeavor(®) zotarolimus stent
por: Bridges, Jonathan, et al.
Publicado: (2008)

Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry
por: Maeng, Michael, et al.
Publicado: (2012)

Simultaneous Multi-Vessel Subacute Stent Thromboses in Zotarolimus-Eluting Stents
por: Kim, Yong-Hyun, et al.
Publicado: (2010)

Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost
por: Arat Ozkan, Alev, et al.
Publicado: (2016)

Two-year clinical outcomes of patients treated with the dual-therapy stent in a 1000 patient all-comers registry
por: Kalkman, Deborah N, et al.
Publicado: (2017)

Two Cases of Immediate Stent Fracture after Zotarolimus-Eluting Stent Implantation
por: Lee, Pil Hyung, et al.
Publicado: (2015)

A Prospective, observational, Italian multi-center registry of self-aPposing(®) cOronary Stents in patients presenting with ST-segment Elevation Myocardial InfarcTION: The iPOSITION registry
por: Giuliani, Livio, et al.
Publicado: (2021)

Comparison of long-term clinical outcomes among zotarolimus-, everolimus-, and biolimus-eluting stents in acute myocardial infarction patients with renal impairment
por: Oh, Seok, et al.
Publicado: (2022)

Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents
por: Kim, J-S, et al.
Publicado: (2009)

The Resolute™ Integrity Zotarolimus-Eluting Stent in Coronary Artery Disease: A Review
por: Banerjee, Subhash
Publicado: (2013)

Longitudinal deformation of a third generation zotarolimus eluting stent: “The concertina returns!”
por: Panoulas, Vasileios F, et al.
Publicado: (2017)

Balloon embedded bifurcation stenting with single stent for side branch protection – Preliminary results from an Indian population
por: Vinayakumar, Desabandhu, et al.
Publicado: (2018)

Delayed coronary obstruction after lotus transcatheter aortic valve replacement treated with left main stent in stent implantation
por: Krisper, Maximilian, et al.
Publicado: (2019)

Calcific lesion preparation for coronary bifurcation stenting
por: Perfetti, Matteo, et al.
Publicado: (2019)

Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease
por: Müller-Hülsbeck, Stefan, et al.
Publicado: (2016)

Five-Year Comparative Efficacy of Everolimus-Eluting vs. Resolute Zotarolimus-Eluting Stents in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Koni, Endrin, et al.
Publicado: (2021)

Comparison of 12-Month Outcomes with Zotarolimus- and Paclitaxel-Eluting Stents: A Meta-Analysis
por: Loomba, Rohit S., et al.
Publicado: (2011)

Nobori-Biolimus-Eluting Stents versus Resolute Zotarolimus-Eluting Stents in Patients Undergoing Coronary Intervention: A Propensity Score Matching
por: Tantawy, Ayman, et al.
Publicado: (2017)

Optimal fluoroscopic viewing angles for stenting of the coronary aorto-ostial lesions
por: Targoński, Radosław, et al.
Publicado: (2021)

Shockwave intracoronary lithotripsy for the treatment of calcium-mediated undilatable in-stent restenosis
por: Kuzemczak, Michał, et al.
Publicado: (2022)

Mechanical performance and healing patterns of the novel sirolimus-eluting bioresorbable Fantom scaffold: 6-month and 9-month follow-up by optical coherence tomography in the FANTOM II study
por: Simonsen, Jo Krogsgaard, et al.
Publicado: (2019)

Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent
por: Improta, Riccardo, et al.
Publicado: (2021)

Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch: the Nordic-Baltic Bifurcation Study IV
por: Kumsars, Indulis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0od7oopvmjeep01oh1pgc8a58q